Susquehanna International Group
TYRA icon

Susquehanna International Group’s Tyra Biosciences TYRA Stock Holding History

Susquehanna International Group’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
+29,900
New +$968K ﹤0.01% 7529

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Susquehanna International Group's TYRA Position: Q1 2026 in Review

Susquehanna International Group reduced its Tyra Biosciences (TYRA) stake by 72% in Q1 2026, selling an estimated $1.28M and leaving 15,543 shares worth $595K. The position accounts for ﹤0.01% of the portfolio, ranked #9218.

Susquehanna International Group first reported a position in TYRA in Q2 2022 and has held it in 6 quarters since. The position peaked at $1.45M in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Susquehanna International Group held 15,543 shares of Tyra Biosciences worth $595K as of Q1 2026.
  • Susquehanna International Group sold 39,592 Tyra Biosciences shares in Q1 2026, an estimated $1.28M.
  • Tyra Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9218 holding.
  • Susquehanna International Group first reported a position in Tyra Biosciences in Q2 2022 and has held it in 6 quarters since.
  • Susquehanna International Group's Tyra Biosciences position peaked at $1.45M in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.